CoChat

Pharmacological interventions for prevention and management of delirium in intensive care patients: a systematic overview of reviews and meta-analyses

Open access

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Abstract

Objectives: We assessed the evidence from reviews and meta-analyses of randomised clinical trials on the effects of pharmacological prevention and management of delirium in intensive care unit (ICU) patients. Methods: We searched for reviews in July 2017 in: Cochrane Library, MEDLINE, Embase, Science Citation Index, BIOSIS Previews, CINAHL and LILACS. We assessed whether reviews were systematic according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and assessed the methodological quality using ROBIS. Outcome measures: Primary outcomes: all-cause mortality, serious adverse events, prevention of delirium and management of delirium. Secondary outcomes: quality of life; non-serious adverse events and cognitive function. Results: We included 378 reviews: 369 narrative reviews, eight semisystematic reviews which failed on a maximum of two arbitrary PRISMA criteria and one systematic review fulfilling all 27 PRISMA criteria. For the prevention of delirium, we identified the one systematic review and eight semisystematic reviews all assessing the effects of alpha-2-agonists. None found evidence of a reduction of mortality (systematic review RR 0.99, 95% CI 0.79 to 1.24). The systematic review and three semisystematic reviews found no evidence of an effect for the prevention of delirium (systematic review RR 0.85, 0.63 to 1.14). Conversely, four semisystematic reviews found a beneficial effect. Serious adverse events, quality of life, non-serious adverse events and cognitive function were not assessed. We did not identify any systematic or semisystematic reviews addressing other pharmacological interventions for the prevention of delirium. For the management of manifest delirium, we did not identify any systematic or semisystematic review assessing any pharmacological agents. Conclusion: Based on systematic reviews, the evidence for the use of pharmacological interventions for prevention or management of delirium is poor or sparse. A systematic review with low risk of bias assessing the effects of pharmacological prevention of delirium and management of manifest delirium in ICU patients is urgently needed. PROSPERO registration number: CRD42016046628.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2018-024562

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Preferred reporting items for systematic reviews and meta-analyses flowchart.
Figure 1 Preferred reporting items for systematic reviews and meta-analyses flowchart.CC BY-NC · PubMed Central
Figure 2 Risk of bias summary: review authors’ judgements about each risk of bias item for each included trial in the only included systematic review (Chen 2015).
Figure 2 Risk of bias summary: review authors’ judgements about each risk of bias item for each included trial in the only included systematic review (Chen 2015).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 4

  1. George, 2009, Managing delirium in Intensive care, Intensive Care Medicine, 35, s258
  2. Meyer, 2011, A multi-center characterization of antipsychotic use for the treatment of delirium in medical ICU patients, Pharmacotherapy, 31
  3. Veritas Health Innovation. Covidence systematic review software. Melbourne, Australia, 2018. https://www.covidence.org/. (Accessed Mar 2018).
  4. Xu JB, 2012, A combined protocol for dexmedetomidine used in prolonged sedation in intensive care unit, Modern Medicine Journal of China, 14, 20

Cited by

See all 54

Metadata

Authors
Barbateskovic, M., Krauss, S. R., Collet, M. O., Larsen, L. K., Jakobsen, J. C., Perner, A., & Wetterslev, J.
Affiliations
Copenhagen University Hospital (DK)
Corresponding author
Barbateskovic, Marija
Venue
BMJ Open
Publisher
BMJ
Published
2019-02
Volume
9
Issue
2
Pages
e024562
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2911573187
Cited by
54
References
82
Citations by year
2026: 3 · 2025: 8 · 2024: 7 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 7 · 2019: 8
FWCI
6.91
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by-nc)
  • HighWire Press Open Archive (submittedVersion)
Funders
Innovation Fund Denmark
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
Keywords
delirium, delirium prevention, delirium management, intensive care unit patients, pharmacological interventions, alpha-2 adrenergic agonists, mortality, adverse events, cognitive function, quality of life, methodological quality of reviews
MeSH terms
Cognition, Critical Care, Delirium, Humans, Intensive Care Units, Mortality, Quality of Life, Review Literature as Topic, Meta-Analysis as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.